Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain.

Abstract excerpt

Curariform alkaloids competitively inhibit muscle acetylcholine receptors (AChR) by bridging the alpha and non-alpha subunits that form the ligand-binding site. Here we delineate bound orientations of d-tubocurarine (d-TC) and its methylated derivative metocurine using mutagenesis, ligand binding measurements, and computational methods. When tested against a series of lysine mutations in the epsilon subunit, the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alkaloids
• Share to Binding Sites
• Share to Cell Line